title: The impact of impurities in synthetic peptides on the outcome of T-cell stimulation assays.
abstract: Protein-spanning peptide pools have proven valuable as a screening tool for detecting T-lymphocyte responses against a wide range of proteins. We have used this approach in our search for T cells reactive to the onconeural protein HuD. We found positive responses in only 3 of 127 individuals; however, these were highly unusual in that the same class I HLA alleles and peptides were involved. These T-cell responses were not confirmed when peptides re-synthesized by the same manufacturer with similar and with higher purity levels were used. Our observations indicated that these T-cell responses were not directed against the designed HuD peptides. Here, we report on (i) comparisons of the peptide batches analyzed by matrix-assisted laser desorption/ionization Fourier transform mass spectrometry (MALDI-FTMS) that did--and did not--elicit T-cell responses and (ii) a detailed analysis of the various by-products of peptides, irrespective of T-cell assay outcome. We found numerous differences between the peptide batches, such as omissions of amino acids in the primary structure of the peptides. Furthermore, some batches revealed strong interactions with calcium ions or contained sulfated peptides. Our data reveal that different batches from the same peptide may contain artefacts that influence the outcome of HLA-restricted T-cell response assays.
authors.affiliation: Laboratory of Neuro-Oncology, Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands.
authors.forename: Janet W
authors.initials: JW
authors.lastname: de Beukelaar
authors.forename: Jan W
authors.initials: JW
authors.lastname: Gratama
authors.forename: Peter A Sillevis
authors.initials: PA
authors.lastname: Smitt
authors.forename: Georges M
authors.initials: GM
authors.lastname: Verjans
authors.forename: Jaco
authors.initials: J
authors.lastname: Kraan
authors.forename: Theo M
authors.initials: TM
authors.lastname: Luider
authors.forename: Peter C
authors.initials: PC
authors.lastname: Burgers
mesh_terms: D001681:Biological Assay / Q000379:methods*; D002478:Cells, Cultured; D004340:Drug Contamination; D015195:Drug Design; D051959:ELAV Proteins / Q000276:immunology*; D006801:Humans; D007118:Immunoassay / Q000379:methods*; D008213:Lymphocyte Activation / Q000187:drug effects / Q000276:immunology; D019151:Peptide Library; D010455:Peptides / Q000737:chemistry* / Q000276:immunology*; D012680:Sensitivity and Specificity; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*
chemical_list: D051959:ELAV Proteins; D019151:Peptide Library; D010455:Peptides